In this presentation, Anand A. Patel, MD, reviewed the contemporary standard-of-care treatment roadmap for AML in 2025, covering key phases like induction chemotherapy (eg, the “7+3” regimen), consolidation…
Eunice S. Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, New York, discusses the treatment strategies for patients who develop secondary acute myeloid leukemia (AML) following hypomethylating agent…
NEW YORK (Reuters Health) – A Canadian guideline on ovarian ablation in premenopausal women with breast cancer has been endorsed by the American Society of Clinical Oncology (ASCO),…
NEW YORK (Reuters Health) – An analysis of epidemiologic data confirms that the incidence of second primary malignancies is increased after external beam radiotherapy (EBRT) for stage I…
NEW YORK (Reuters Health) – Dexamethasone may be a useful supplement to standard treatment of certain patients with acute monocytic leukemia, French researchers report in an August 4th…
NEW YORK (Reuters Health) – Surgery offers the best hope for survival in patients with the rare intracranial hemangiopericytoma (HPC), researchers from San Francisco report in the August…
NEW YORK (Reuters Health) – The combination of epirubicin and ifosfamide is effective in patients with relapsed or refractory small cell lung cancer (SCLC), researchers from France report…
NEW YORK (Reuters Health) – Cervical preparation with prostaglandins before outpatient hysteroscopy does not reduce pain in women of reproductive age, researchers from UK report in the July…
NEW YORK (Reuters Health) – Geographically, higher rates of surgery for early stage nonsmall cell lung cancer (NSCLC) are associated with improved survival, even in older and sicker…
NEW YORK (Reuters Health) – In patients newly diagnosed inoperable pancreatic cancer, it’s worth considering celiac plexus neurolysis (CPN) for pain control at the same time that endoscopic…
NEW YORK (Reuters Health) – Postmenopausal women with ovarian cysts detected on ultrasound are not at increased risk of developing ovarian cancer or, for that matter, breast or…
NEW YORK (Reuters Health) – Five-year survival rates are not significantly different for patients with esophagogastric cancer whether they undergo transthoracic or transhiatal esophagectomy, according to the findings…
